Discover
PSTX
Poseida Therapeutics, Inc.
9.50
undefined x undefined
undefined x undefined
bid
ask
+
9.50
0.00%
07:00 PM
| Ytd | -1.04% | |
| 1y | 178.59% |
day range
52 week range
| Open | Prev Close | Low | High | Mkt Cap | N/A | ||||
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -5.64 |
| Beta | 0.54 | Short Ratio | 2.05 | Inst. Own | 58.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 9.50 |
| Income Statement | |||
| Total Revenue | 71.75M | ||
| Revenues (USD) | 71.75M | ||
| Gross Profit | 71.75M | ||
| Operating Expenses | 52.01M | ||
| Research and Development Expense | 41.91M | ||
| Selling, General and Administrative Expense | 10.09M | ||
| Operating Income | 19.74M | ||
| Interest Expense | 2.30M | ||
| Income Tax Expense | 43.00K | ||
| Net Income | 20.24M | ||
| Net Income Common Stock | 20.24M | ||
| Net Income Common Stock (USD) | 20.24M | ||
| Consolidated Income | 20.24M | ||
| Earnings per Basic Share | 0.21 | ||
| Earnings per Basic Share (USD) | 0.21 | ||
| Earnings per Diluted Share | 0.21 | ||
| Earning Before Interest & Taxes (EBIT) | 22.57M | ||
| Earning Before Interest & Taxes (USD) | 22.57M | ||
| Weighted Average Shares | 97.16M | ||
| Weighted Average Shares Diluted | 98.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.34M | ||
| Cash and Equivalents (USD) | 49.34M | ||
| Investments | 181.51M | ||
| Investments Current | 181.51M | ||
| Trade and Non-Trade Receivables | 14.75M | ||
| Current Assets | 250.70M | ||
| Property, Plant & Equipment Net | 36.42M | ||
| Total Assets | 293.58M | ||
| Debt Current | 6.09M | ||
| Total Debt | 82.73M | ||
| Current Liabilities | 78.27M | ||
| Debt Non-Current | 76.64M | ||
| Total Liabilities | 206.37M | ||
| Accumulated Retained Earnings (Deficit) | -629.70M | ||
| Accumulated Other Comprehensive Income | 376.00K | ||
| Shareholders Equity | 87.21M | ||
| Shareholders Equity (USD) | 87.21M | ||
| Assets Non-Current | 42.87M | ||
| Total Debt (USD) | 82.73M | ||
| Deferred Revenue | 85.68M | ||
| Goodwill and Intangible Assets | 5.55M | ||
| Liabilities Non-Current | 128.10M | ||
| Trade and Non-Trade Payables | 5.20M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.32M | ||
| Net Cash Flow from Financing | 742.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 18.80M | ||
| Capital Expenditure | -645.00K | ||
| Net Cash Flow from Investing | 27.65M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 28.29M | ||
| Net Cash Flow from Operations | -9.59M | ||
| Share Based Compensation | 4.96M | ||